These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 6385429)
21. [Type of isoniazid (INH) acetylation determined in tuberculosis patients treated at the Institute of Tuberculosis and Lung Diseases in Warsaw during the years 1990-1997]. Augustynowicz-Kopeć E; Zwolska Z Pneumonol Alergol Pol; 2002; 70(3-4):180-92. PubMed ID: 12271965 [TBL] [Abstract][Full Text] [Related]
22. Population screening for isoniazid acetylator phenotype. Seifart HI; Parkin DP; Botha FJ; Donald PR; Van Der Walt BJ Pharmacoepidemiol Drug Saf; 2001; 10(2):127-34. PubMed ID: 11499851 [TBL] [Abstract][Full Text] [Related]
23. Risk factors for hepatotoxicity during anti-tuberculosis chemotherapy in Asian populations. Yew WW Int J Tuberc Lung Dis; 2001 Jan; 5(1):99-100. PubMed ID: 11263525 [No Abstract] [Full Text] [Related]
24. Acetylator phenotype key to INH side effects. Forester D Ann Emerg Med; 1980 Mar; 9(3):173. PubMed ID: 7362111 [No Abstract] [Full Text] [Related]
26. Levels of acetyl hydrazines and rate of acetylation of isoniazid in adult tuberculosis patients. Bhalerao EB; Bhide SV Indian J Physiol Pharmacol; 1985; 29(2):83-8. PubMed ID: 4093196 [TBL] [Abstract][Full Text] [Related]
27. [Phenotype of isoniazid acetylation and tolerance of antitubercular drugs]. Gontsa FT; Savina LA; Tsurkan VP; Kovalenko IP Probl Tuberk; 1988; (2):35-8. PubMed ID: 3375215 [No Abstract] [Full Text] [Related]
28. [Incidence of hepatotoxic side effects during antituberculous therapy (INH, RMP, EMB) in relation to the acetylator phenotype (author's transl)]. Musch E; Eichelbaum M; Wang JK; von Sassen W; Castro-Parra M; Dengler HJ Klin Wochenschr; 1982 May; 60(10):513-9. PubMed ID: 7098379 [TBL] [Abstract][Full Text] [Related]
29. Twice-weekly streptomycin plus isoniazid for tuberculosis. Stradling P; Poole GW Tubercle; 1970 Mar; 51(1):44-7. PubMed ID: 5495335 [No Abstract] [Full Text] [Related]
30. Simplified isoniazid acetylator phenotyping. Russell DW; Eidus L Can Med Assoc J; 1972 Jun; 106(11):1155-6. PubMed ID: 5034694 [No Abstract] [Full Text] [Related]
31. Isoniazid acetylation rates (phenotypes) of patients being treated for tuberculosis. Mason E; Russell DW Bull World Health Organ; 1971; 45(5):617-24. PubMed ID: 5316954 [TBL] [Abstract][Full Text] [Related]
32. Acetylator phenotyping of tuberculosis patients using matrix isoniazid or sulphadimidine and its prognostic significance for treatment with several intermittent isoniazid-containing regimens. Ellard GA; Gammon PT Br J Clin Pharmacol; 1977 Feb; 4(1):5-14. PubMed ID: 843424 [TBL] [Abstract][Full Text] [Related]
35. Importance of acetylation and oxidation in inactivation of isonicotinic acid hydrazide preparations. Smirnov GA Fed Proc Transl Suppl; 1966; 25(1):72-6. PubMed ID: 5322111 [No Abstract] [Full Text] [Related]
36. Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis. Parkin DP; Vandenplas S; Botha FJ; Vandenplas ML; Seifart HI; van Helden PD; van der Walt BJ; Donald PR; van Jaarsveld PP Am J Respir Crit Care Med; 1997 May; 155(5):1717-22. PubMed ID: 9154882 [TBL] [Abstract][Full Text] [Related]
37. Hepatic function in relation to acetylator phenotype in children treated with antitubercular drugs. Seth V; Beotra A Indian J Med Res; 1989 Sep; 89():306-9. PubMed ID: 2628292 [TBL] [Abstract][Full Text] [Related]
38. Isoniazid phenotyping in Munda and Oraon tribes of Chhotanagpur division suffering from pulmonary tuberculosis by sulphadimidine acetylation test. Sinha CP; Sinha S; Sinha KP; Choudhary KD Indian J Med Sci; 1980 Aug; 34(8):189-92. PubMed ID: 7203584 [No Abstract] [Full Text] [Related]
39. Complete sequencing of a genetic polymorphism in NAT2 in the Korean population. Lee SY; Lee KA; Ki CS; Kwon OJ; Kim HJ; Chung MP; Suh GY; Kim JW Clin Chem; 2002 May; 48(5):775-7. PubMed ID: 11978608 [No Abstract] [Full Text] [Related]
40. Effects of two pulmonary tuberculosis drug treatments and acetylator status on liver function in a Zimbabwean population. Neill P; Pringle D; Mhonda M; Kusema T; Nhachi CF Cent Afr J Med; 1990 Apr; 36(4):104-7. PubMed ID: 2225025 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]